The median duration of symptoms for participants receiving placebo was 1167 h ( 95 % CI 1081-1221 ) compared with 955 h ( 840-1080 ; p = 00084 ) for those receiving 600 mg nitazoxanide and 1091 h ( 961-1295 , p = 052 ) for those receiving 300 mg nitazoxanide .